Peter D. Kies
2011
In 2011, Peter D. Kies earned a total compensation of $453.4K as Chief Financial Officer at Inovio Pharmaceuticals, a 60% increase compared to previous year.
Compensation breakdown
| Bonus | $78,300 |
|---|---|
| Option Awards | $113,003 |
| Salary | $257,351 |
| Other | $4,786 |
| Total | $453,440 |
Kies received $257.4K in salary, accounting for 57% of the total pay in 2011.
Kies also received $78.3K in bonus, $113K in option awards and $4.8K in other compensation.
Rankings
In 2011, Peter D. Kies' compensation ranked 8,353rd out of 10,747 executives tracked by ExecPay. In other words, Kies earned more than 22.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,353 out of 10,747 | 22nd |
Division Manufacturing | 3,075 out of 3,960 | 22nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 471 out of 642 | 27th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 253 out of 356 | 29th |
Industry Surgical and Medical Instruments and Apparatus | 155 out of 216 | 28th |
Source: SEC filing on April 6, 2012.
Kies' colleagues
We found five more compensation records of executives who worked with Peter D. Kies at Inovio Pharmaceuticals in 2011.
2011
J Kim
Inovio Pharmaceuticals
Chief Executive Officer
2011
Avtar Dhillon
Inovio Pharmaceuticals
Chairman
2011
Niranjan Sardesai
Inovio Pharmaceuticals
Chief Operating Officer
2011
Niranjan Sardesei
Inovio Pharmaceuticals
Chief Operating Officer
2011
Mark Bagarazzi
Inovio Pharmaceuticals
Chief Medical Officer
News
Inovio Pharmaceuticals CEO Jacqueline Shea's 2023 pay falls 31% to $2.4M
April 11, 2024
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019